News and Policies
COVID-19 vaccine commercial production plant put into use in Yantai
Updated: Dec 16, 2021
chinadaily.com.cn
Print
Share - WeChat
A commercial production plant for COVID-19 vaccines was put into use in Yantai, a coastal city of Shandong province on Dec 1.
Operated by the Luye Life Sciences Group, the plant has an annual production capacity of 1 billion doses of vaccines. It is also Shandong's first VLP vaccine commercial production facility.
The 21,000-square-meter plant will mainly produce the LYB001 COVID-19 vaccine.
The plant is able to boost its production capacity to 2 billion doses or higher and support overseas clinical research and commercial production.
MOST POPULAR
- 1 China to give visa-free treatment to another 9 countries
- 2 China fully opens manufacturing sector to foreign investors in landmark opening up move
- 3 China's import expo attracts record-breaking participating countries, exhibitors
- 4 China's door opening even wider to foreign visitors, businesses
- 5 China revises rules to ease foreign strategic investment in listed firms
Editors' Picks
Video:
Peru sees new port open
Infographic:
China's public holidays for 2025
Infographic:
Basic facts of APEC
Infographic:
Wrapping up the 7th CIIE: Data recap
